| Financial Year |
March 31 2023 |
| Monetary Funds |
3,098,134,716.50 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
116,992,717.90 |
| Advances to Suppliers |
124,474,995.58 |
| Other Receivables |
224,728,797.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
15,313,833,557.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
631,752,303.86 |
| Total Current Assets |
19,509,929,260.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
52,746,649.65 |
| Investment Properties |
147,256,100.00 |
| Fixed Assetes |
16,702,194.63 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,551,868.48 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
15,577,907.76 |
| Deferred Income Tax Assets |
229,565,098.17 |
| Other Non-Current Assets |
328,626,724.51 |
| Sub-Total of Non-Current Assets |
810,226,967.41 |
| Total Assets |
20,320,156,228.40 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,284,320,487.59 |
| Accounts Received In Advance |
92,502,357.49 |
| Employee Compensation Payable |
19,820,003.69 |
| Taxes Payable |
464,994,452.30 |
| Interest Payable |
5,704,166.67 |
| Dividend Payable |
97,697,058.17 |
| Other payables |
380,115,991.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
267,855,115.45 |
| Other Current Liabilities |
470,456,318.57 |
| Sub-Total of Current Liabilities |
7,053,763,470.24 |
| Long-term Loans |
5,657,145,502.54 |
| Bonds Payable |
1,425,000,000.00 |
| Long-Term Accounts Payable |
425,945,941.67 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
22,178,794.00 |
| Other Non-Current Liabilities |
71,545,783.61 |
| Sub-Total of Non-Current Liabilities |
7,607,134,201.40 |
| Total Liabilities |
14,660,897,671.64 |
| Paid-In Capital(Or Share Stock) |
452,880,000.00 |
| Capital Surplus |
11,381,476.19 |
| Surplus Reserve |
211,955,350.73 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
564,215,878.97 |
| Minority Stockholder's Interest |
2,109,653,138.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,549,605,418.11 |
| Owner's Equity（Stockholder's Equity） |
5,659,258,556.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
20,320,156,228.40 |
